The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes
Clinical trial NCT03641352 · UNKNOWN
Trial details
- NCT number
- NCT03641352
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2021-04-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.